Detection of left ventricular diffuse fibrosis with quantitative T1 mapping in patients with paroxysmal atrial fibrillation by Raymond H Chan et al.
POSTER PRESENTATION Open Access
Detection of left ventricular diffuse fibrosis with
quantitative T1 mapping in patients with
paroxysmal atrial fibrillation
Raymond H Chan*, Murilo Foppa, Sebastian Weingärtner, Kraig V Kissinger, Beth Goddu, Warren J Manning,
Reza Nezafat
From 16th Annual SCMR Scientific Sessions
San Francisco, CA, USA. 31 January - 3 February 2013
Background
Background: Quantitation of T1 relaxation times (T1 time)
is a novel non-invasive CMR technique which can detect
both interstitial and replacement fibrosis. T1 changes
consistent with interstitial fibrosis have been described in
conditions associated with left ventricular (LV) remodeling
and systolic dysfunction, including chronic mitral regurgi-
tation and aortic stenosis. Atrial fibrillation (AF) is also
associated with left ventricular (LV) remodelling. With AF,
fibrosis develops in the atrium in AF, but it is unknown
whether the same processes occur in the left ventricle.
Hypothesis: We hypothesized that patients with paroxys-
mal AF would demonstrate CMR evidence of LV fibrosis,
exhibiting decreased T1 times compared with control
patients.
Methods
We prospectively enrolled 35 patients referred for a
contrast-enhanced cardiac MR scan at 1.5T for clinical
purposes and were in sinus rhythm during the time of
the scan. Seventeen patients had paroxysmal AF, while
18 had no CMR evidence of structural or valvular
abnormalities (controls). A Modified Look-Locker Inver-
sion Recovery (MOLLI) sequence was acquired before
and after bolus administration of 0.1 mmol/kg gadobe-
nate dimeglumine (Multihance) for 3 short-axis slices.
T1 times were measured in the entire LV myocardium
of the 3 slices, and the values for the 3 slices were then
averaged to reflect the overall T1 time of the entire LV.
Results
The 35 patients included in the analysis comprised of
60% men (age 56±14 years). Baseline characteristics
were similar between AF (n=17) and control (n=18)
groups (age 59±12 vs 53±16 yrs, p=0.27; ejection frac-
tion (EF) 56±13 vs 60±5%, p=0.29; LV mass index 57
±17 vs 56 ± 16 g/m2, p=0.88, end diastolic volume 173
±59 vs 163 ±44 ml, p=0.57, stroke volume 90±17 vs 97
±24 ml, p=0.33). Pre-contrast T1 times were not signifi-
cantly different between those with AF and the control
group (1028 ± 67 vs 1012 ± 37 ms, p=0.47). However,
post-contrast T1 times were significantly lower in those
with AF (395 ± 69 vs 447 ± 67 ms, p=0.04). After con-
trolling for EF and time after contrast injection, patients
with AF continued to exhibit significantly lower T1
times compared with controls (adjusted difference= -46
± 21 ms, p=0.04).
Conclusions
Atrial fibrillation is associated with a significantly lower
post-contrast T1 time, without an apparent decrease in
the pre-contrast T1 time. These findings suggest post-
contrast T1 mapping may be more sensitive in detecting
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